Back to search
FDAFDA · Food and drugs·Recall number D-0356-2021

Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60

Published April 28, 2021 · Recall initiated: April 9, 2021

Summary

FDA records drug Class II recall D-0356-2021, published April 28, 2021 and initiated April 9, 2021. Recalling firm: Teligent Pharma, Inc.; Status: Ongoing; Reported quantity: 3432 tubes; Lot: Lot #13974 EXP 7/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications:

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teligent Pharma, Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot #13974 EXP 7/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60 recalled?

Yes. FDA published recall D-0356-2021 on April 28, 2021. Reported hazard: Failed Impurities/Degradation Specifications:

What should I do if I have this product?

Voluntary: Firm initiated · Letter